Browse our anti-CYP7A1 (CYP7A1) Antibodies

Full name:
anti-Cytochrome P450, Family 7, Subfamily A, Polypeptide 1 Antibodies (CYP7A1)
On www.antibodies-online.com are 43 Cytochrome P450, Family 7, Subfamily A, Polypeptide 1 (CYP7A1) Antibodies from 14 different suppliers available. Additionally we are shipping CYP7A1 Kits (48) and CYP7A1 Proteins (8) and many more products for this protein. A total of 104 CYP7A1 products are currently listed.
Synonyms:
CHAP, CP7A, CYP7, CYP7S1, CYPVII
list all antibodies Gene Name GeneID UniProt
CYP7A1 1581 P22680
CYP7A1 13122 Q64505
CYP7A1 25428 P18125

Show all species

Show all synonyms

Most Popular Reactivities for anti-CYP7A1 (CYP7A1) Antibodies

Select your species and application

anti-Human CYP7A1 Antibodies:

anti-Mouse (Murine) CYP7A1 Antibodies:

anti-Rat (Rattus) CYP7A1 Antibodies:

All available anti-CYP7A1 Antibodies

Go to our pre-filtered search.

Top referenced anti-CYP7A1 Antibodies

  1. Human Polyclonal CYP7A1 Primary Antibody for IF (p), IHC (p) - ABIN739725 : Gabbi, Bertolotti, Anzivino, Macchioni, Del Puppo, Ricchi, Carubbi, Tagliafico, Romagnoli, Odoardi, Loria, Losi, Carulli: Effects of bile duct ligation and cholic acid treatment on fatty liver in two rat models of non-alcoholic fatty liver disease. in Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 2012 (PubMed)
    Show all 6 references for 739725

  2. Human Polyclonal CYP7A1 Primary Antibody for EIA, WB - ABIN360417 : Lenícek, Komárek, Zimolová, Kovár, Jirsa, Lukás, Vítek: CYP7A1 promoter polymorphism -203A>C affects bile salt synthesis rate in patients after ileal resection. in Journal of lipid research 2008 (PubMed)
    Show all 2 references for 360417

More Antibodies against CYP7A1 Interaction Partners

Human Cytochrome P450, Family 7, Subfamily A, Polypeptide 1 (CYP7A1) interaction partners

  1. Current studies suggest that increased Cyp7a1 expression and bile acid synthesis ameliorate hepatic inflammation through activation of FXR (show NR1H4 Antibodies)

  2. This study provides evidence that individuals carrying the G allele of CYP7A1 single nucleotide polymorphism are more responsive to high molecular weight beta-glucan's effect of lowering circulating cholesterol concentrations than individuals homozygous for the T allele.

  3. Genetic variations in ABCG5 (show ABCG5 Antibodies), CYP7A1, and DHCR7 (show DHCR7 Antibodies) may contribute to differing responses of serum cholesterol to dairy intake among healthy adults.

  4. The promoter polymorphism of the CYP7A1 gene has a pronounced impact on diurnal variation in CYP7A1 activity.

  5. The finding that overexpression of HIF-1alpha (show HIF1A Antibodies) increased the activity of the CYP7A1 promoter suggested that hypoxia decreased the expression of CYP7A1 in a HIF-1 (show HIF1A Antibodies)-independent manner.

  6. Macrophage cholesterol efflux in patients with type II diabetes mellitus was significantly reduced, and that this reduction was associated with the down-regulation of CYP7A1 expression.

  7. CYP7A1 and APOE (show APOE Antibodies) isoform are associated with the extent of reduction in circulating LDL cholesterol in response to plant sterols consumption.

  8. The CYP7A1 rs7833904 polymorphism may modify the risk of CAD (show CAD Antibodies).

  9. The CYP7A1 crystallographic models identify residues involved in cholest-4-en-3 (show EN1 Antibodies)-one binding.

  10. we identified for the first time a significant association of the A-204C polymorphism of the CYP7A1 gene and development of tuberculosis in a Moroccan population

Mouse (Murine) Cytochrome P450, Family 7, Subfamily A, Polypeptide 1 (CYP7A1) interaction partners

  1. Cyp7a1(-/-) mice have improved glucose sensitivity with reduced liver triglycerides and fecal bile acid excretion, but increased fecal fatty acid excretion and respiratory exchange ratio (RER) when fed a high-fat/high-cholesterol diet

  2. Current studies suggest that increased Cyp7a1 expression and bile acid synthesis ameliorate hepatic inflammation through activation of FXR (show NR1H4 Antibodies)

  3. HSF-1 (show HSF1 Antibodies) ablation not only eliminates heat shock response, but it also transcriptionally up-regulates CYP7A1 and MDR1/P-gp (show ABCB4 Antibodies) axis in WD-diet fed HSF-1 (show HSF1 Antibodies)(-/-)/LDLr (show LDLR Antibodies)(-/-) mice to reduce atherosclerosis.

  4. Mice deficient in cholesterol 7 alpha-hydroxylase, supplemented with chenodeoxycholic acid, have altered liver and intestinal bile acids.

  5. Activation of the VDR (show CYP27B1 Antibodies) represses hepatic SHP (show LAMC1 Antibodies) to increase levels of CYP7A1 and reduce cholesterol.

  6. Cholesterol lowering properties of oats involve increased production of bile acids via the classic pathway with up-regulation of CYP7A1 and CYP8B1 (show CYP8B1 Antibodies).

  7. A CYP7A1/SREBP2 (show SREBF2 Antibodies)/miR (show MLXIP Antibodies)-33a axis plays a critical role in regulation of hepatic cholesterol, bile acid, and fatty acid synthesis.

  8. Ileal Fibroblast Growth Factor-15 (FGF15) expression was significantly reduced in Asbt (show SLC10A2 Antibodies)(-/-)apoE (show APOE Antibodies)(-/-) mice and was inversely correlated with expression of hepatic cholesterol 7-hydroxylase (Cyp7a1).

  9. HNF4alpha (show HNF4A Antibodies) and LRH-1 (show NR5A2 Antibodies) promote active transcription histone marks on the Cyp7a1 promoter that are reversed by FGF19 (show FGF19 Antibodies) in a SHP (show LAMC1 Antibodies)-dependent manner

  10. these data suggest that FGF7 (show FGF7 Antibodies) is a novel regulator of CYP7A1 expression in hepatocytes and may prevent hepatocytes from accumulating toxic bile acids during liver injury and fibrosis.

Pig (Porcine) Cytochrome P450, Family 7, Subfamily A, Polypeptide 1 (CYP7A1) interaction partners

  1. the effect of polymorphism in the cholesterol 7-alpha hydroxylase gene locus and dietary cholesterol on cerebrum cholesterol in neonatal pigs fed sow's milk formulas are reported.

CYP7A1 Antigen Profile

Antigen Summary

This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This endoplasmic reticulum membrane protein catalyzes the first reaction in the cholesterol catabolic pathway in the liver, which converts cholesterol to bile acids. This reaction is the rate limiting step and the major site of regulation of bile acid synthesis, which is the primary mechanism for the removal of cholesterol from the body. Polymorphisms in the promoter of this gene are associated with defects in bile acid synthesis.

Alternative names and synonyms associated with CYP7A1

  • cholesterol 7-alpha-hydroxylase (Cyp7a1) antibody
  • cytochrome P450, family 7, subfamily A, polypeptide 1 (CYP7A1) antibody
  • cytochrome P450, family 7, subfamily a, polypeptide 1 (Cyp7a1) antibody
  • CHAP antibody
  • CP7A antibody
  • CYP7 antibody
  • CYP7S1 antibody
  • CYPVII antibody

Protein level used designations for CYP7A1

cholesterol 7-alpha-hydroxylase , cholesterol 7-alpha-monooxygenase , cytochrome P450 7A1 , cytochrome P450, subfamily VIIA polypeptide 1 , CYPVII , cholesterol 7 alpha hydroxylase , cytochrome P450, 7a1 , cholesterol 7-alpha hydroxylase , cytochrome P450 (cholesterol hydroxylase 7 alpha) , cholesterol 7alpha-hydroxylase , cholesterol 7 alpha-hydroxylase

GENE ID SPECIES
100337633 Cavia porcellus
1581 Homo sapiens
13122 Mus musculus
25428 Rattus norvegicus
448985 Sus scrofa
100328551 Oryctolagus cuniculus
414834 Gallus gallus
Selected quality suppliers for anti-CYP7A1 (CYP7A1) Antibodies
Did you look for something else?